A new personalized mRNA vaccine for melanoma is being hailed by some oncologists as a major breakthrough after it reduced the risk of cancer recurrence and death by 42% compared with standard ...

A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.

When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage ...

Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 ...

Akeso, Inc. (HKEX: 9926.HK) today announced that Summit Therapeutics Inc. (NASDAQ: SMMT), its global partner for ivonescimab, has entered ...

The clinical-scale mRNA manufacturing and R&D facility is one of three strategic pillars of BioNTech's presence in Australia, which is focused on contributing to the local mRNA ecosystem as well as ...

Targeted lipid nanoparticles generate CAR NK cells in mice, showing activity against cancer and autoimmune liver disease ...

Progestogen, when used in hormone therapy, is recognized for its benefits in protecting the uterus. A new study suggests that ...

Our genes evolved to fight ancient threats, but in the modern world, some of those changes may be turning against us.

Co., Ltd. ("Vivacta Bio"), a company spun out of the in vivo CAR-T platform of Beijing Grit Biotherapeutics Co., Ltd. ("Grit ...

A new study integrating bulk and single-cell RNA sequencing identifies two mitochondrial quality control-related genes with ...

Government support, private-public investment, global collaborations and a rich mRNA pipeline create opportunities across vaccines, oncology and personalized medicineDublin, Oct. 16, 2026 (GLOBE ...